PubRank
Search
About
S Miehlke
Author PubWeight™ 40.94
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin.
Proc Natl Acad Sci U S A
1999
4.55
2
Probe-based confocal laser endomicroscopy compared with standard four-quadrant biopsy for evaluation of neoplasia in Barrett's esophagus.
Endoscopy
2010
2.11
3
Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole.
Gastrointest Endosc
2000
1.94
4
The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract.
Aliment Pharmacol Ther
2009
1.92
5
Gastric carcinoma risk index in patients infected with Helicobacter pylori.
Virchows Arch
1998
1.79
6
Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group.
J Crohns Colitis
2012
1.56
7
Impact of reflux disease on general and disease-related quality of life - evidence from a recent comparative methodological study in Germany.
Z Gastroenterol
2003
1.52
8
[Helicobacter pylori and stomach carcinoma. Is a preventive intervention study of value?].
Pathologe
1998
1.45
9
Cure of gastric ulcer disease after cure of Helicobacter pylori infection--German Gastric Ulcer Study.
Eur J Gastroenterol Hepatol
1996
1.40
10
Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection.
J Clin Oncol
2001
1.34
11
Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type.
World J Gastroenterol
2001
1.28
12
Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis?
Best Pract Res Clin Gastroenterol
2001
1.18
13
Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers.
Gastroenterology
1995
1.14
14
Locally advanced small-bowel adenocarcinoma missed primarily by capsule endoscopy but diagnosed by push enteroscopy.
Endoscopy
2003
1.12
15
Differing degree and distribution of gastritis in Helicobacter pylori-associated diseases.
Virchows Arch
1997
1.10
16
Leptin and its receptor in normal human gastric mucosa and in Helicobacter pylori-associated gastritis.
Scand J Gastroenterol
1999
1.04
17
alpha-catenin expression is decreased in human gastric cancers and in the gastric mucosa of first degree relatives.
Gut
2000
1.01
18
Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial.
Aliment Pharmacol Ther
2006
0.97
19
Frequency of TPR-MET rearrangement in patients with gastric carcinoma and in first-degree relatives.
Cancer
2000
0.95
20
Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer.
Cancer Res
2000
0.93
21
Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol.
Clin Pharmacol Ther
2007
0.90
22
Gastric MALT-lymphoma and Helicobacter pylori infection.
Aliment Pharmacol Ther
1997
0.88
23
Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer.
Br J Cancer
2000
0.86
24
Clinical course of collagenous colitis over a period of 10 years.
Z Gastroenterol
2006
0.85
25
Differing patterns of Helicobacter pylori gastritis in patients with duodenal, prepyloric, and gastric ulcer disease.
Scand J Gastroenterol
1998
0.84
26
Less favorable clinical outcome after diagnostic and interventional double balloon enteroscopy in patients with suspected small-bowel bleeding?
Endoscopy
2008
0.80
27
[S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease].
Z Gastroenterol
2016
0.79
28
Fingerprinting of Nigerian Helicobacter pylori isolates by plasmid profile and PCR.
J Basic Microbiol
2002
0.78
29
[Prevention of stomach carcinoma by Helicobacter pylori eradication. Invitation to participate in the PRISMA Study].
Z Gastroenterol
1999
0.78
30
[Portopulmonary hypertension].
Z Gastroenterol
2005
0.78
31
[Current value of quinolones in Helicobacter pylori therapy].
Z Gastroenterol
2011
0.77
32
Genotyping of Nigerian Helicobacter pylori isolates by pulsed-field gel electrophoresis.
J Med Microbiol
2003
0.77
33
Esomeprazole: potent acid suppression in the treatment of acid-related disorders.
Expert Rev Clin Immunol
2005
0.77
34
[S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease].
Z Gastroenterol
2016
0.77
35
[Meta-analysis should be regarded with extreme caution].
Z Gastroenterol
1996
0.75
36
A randomized controlled trial of equivalence between pantoprazole and esomeprazole that does not have the power to conclude.
J Clin Gastroenterol
2005
0.75
37
Time to remission with budesonide in collagenous colitis.
Aliment Pharmacol Ther
2005
0.75
38
Nocturnal oxygen desaturation is a frequent complication in portopulmonary hypertension.
Z Gastroenterol
2008
0.75
39
[Helicobacter pylori eradication therapy with omeprazole and amoxicillin: current status].
Leber Magen Darm
1994
0.75
40
Molecular typing of Nigerian Helicobacter pylori isolates by glmM restriction fragment length polymorphism.
Br J Biomed Sci
2003
0.75
41
[Symptom- versus endoscopy-based diagnosis and treatment of gastroesophageal reflux disease (GERD)].
Z Gastroenterol
2006
0.75
42
Hepatomegaly and cholestasis as primary clinical manifestations of an AL-kappa amyloidosis.
Eur J Gastroenterol Hepatol
1999
0.75